| scholarly article | Q13442814 |
| P356 | DOI | 10.1042/CS20120269 |
| P698 | PubMed publication ID | 23013041 |
| P50 | author | Stephen Harrap | Q30519277 |
| Sheila K Patel | Q57054982 | ||
| Louise M Burrell | Q88223744 | ||
| P2093 | author name string | Elena Velkoska | |
| P2860 | cites work | X-inactivation profile reveals extensive variability in X-linked gene expression in females | Q22122481 |
| A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase | Q22254730 | ||
| A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 | Q24290169 | ||
| Knockdown of ZNF268, which is transcriptionally downregulated by GATA-1, promotes proliferation of K562 cells | Q24301614 | ||
| CTCF: master weaver of the genome | Q24621388 | ||
| The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function | Q24633556 | ||
| Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas | Q24680069 | ||
| ACE2 gene expression is up-regulated in the human failing heart | Q24794580 | ||
| Review article: the pathophysiological roles of the renin-angiotensin system in the gastrointestinal tract | Q27009109 | ||
| The International HapMap Project | Q27860695 | ||
| Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase | Q28115041 | ||
| Angiotensin-converting enzyme 2 is an essential regulator of heart function | Q28205840 | ||
| Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression | Q28583180 | ||
| Plasma ACE2 activity is an independent prognostic marker in Chagas' disease and equally potent as BNP. | Q48315421 | ||
| N-terminal pro-brain natriuretic peptide and angiotensin-converting enzyme-2 levels and their association with postoperative cardiac complications after emergency orthopedic surgery. | Q48633775 | ||
| Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. | Q51374898 | ||
| X chromosome gene expression in human tissues: male and female comparisons. | Q51787931 | ||
| Association of angiotensin-converting enzyme 2 gene A/G polymorphism and elevated blood pressure in Chinese patients with metabolic syndrome. | Q51820362 | ||
| No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension. | Q51995128 | ||
| Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study. | Q52855193 | ||
| Association of ACE, ACE2 and UTS2 polymorphisms with essential hypertension in Han and Dongxiang populations from north-western China. | Q54590701 | ||
| Association of ACE2 Genetic Variants With Blood Pressure, Left Ventricular Mass, and Cardiac Function in Caucasians With Type 2 Diabetes | Q57243271 | ||
| Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men | Q57315164 | ||
| Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions | Q58215379 | ||
| Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease | Q33387233 | ||
| Polymorphisms of angiotensin-converting enzyme (ACE) and ACE2 are not associated with orthostatic blood pressure dysregulation in hypertensive patients | Q33555002 | ||
| Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system | Q33799399 | ||
| Association of genetic variants in the apelin-APJ system and ACE2 with blood pressure responses to potassium supplementation: the GenSalt study | Q33932245 | ||
| Genetic variants in the apelin system and blood pressure responses to dietary sodium interventions: a family-based association study | Q34001103 | ||
| Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy. | Q34480216 | ||
| The angiotensin-converting enzyme gene family: genomics and pharmacology | Q34586915 | ||
| ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. | Q34784864 | ||
| Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. | Q34830604 | ||
| Genes that escape from X inactivation | Q35104916 | ||
| Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit | Q35152116 | ||
| Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes. | Q35229766 | ||
| Angiotensin-converting enzyme 2: the first decade | Q35550937 | ||
| Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system | Q35567432 | ||
| Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. | Q35597966 | ||
| ACE2, a new regulator of the renin-angiotensin system | Q35756519 | ||
| Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy | Q36773270 | ||
| Genetic variation in angiotensin-converting enzyme-related pathways associated with sudden cardiac arrest risk | Q37375407 | ||
| Progression of cardiovascular damage: the role of renin-angiotensin system blockade | Q37681732 | ||
| Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease | Q37811789 | ||
| A polymorphic miR-155 binding site in AGTR1 is associated with cardiac hypertrophy in Friedreich ataxia. | Q37902766 | ||
| Renal function and blood pressure: molecular insights into the biology of endothelin-1. | Q37926823 | ||
| Association between renin-angiotensin-aldosterone system-related genes and blood pressure in a Korean population | Q38476861 | ||
| Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2) and inhibits shedding of its ectodomain | Q40037190 | ||
| Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor. | Q40130425 | ||
| Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). | Q40404194 | ||
| Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. | Q40510688 | ||
| Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7). | Q42447014 | ||
| Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. | Q44353743 | ||
| Angiotensin converting enzyme 2 gene expression increased compensatory for left ventricular remodeling in patients with end-stage heart failure | Q45094749 | ||
| Myocardial infarction increases ACE2 expression in rat and humans. | Q45238600 | ||
| Onset of experimental severe cardiac fibrosis is mediated by overexpression of Angiotensin-converting enzyme 2. | Q46120246 | ||
| ACE2 gene polymorphism and essential hypertension: an updated meta-analysis involving 11,051 subjects | Q46273463 | ||
| Identification of angiotensin converting enzyme 2 in the rodent retina. | Q46374769 | ||
| Immunolocalization of ACE2 and AT2 receptors in rabbit atherosclerotic plaques. | Q46663979 | ||
| Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls | Q46678604 | ||
| Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients | Q46716852 | ||
| Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. | Q46966464 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 65-76 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Clinical Science | Q372419 |
| P1476 | title | The ACE2 gene: its potential as a functional candidate for cardiovascular disease | |
| P478 | volume | 124 |
| Q35760437 | ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy |
| Q38567063 | ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension |
| Q94947170 | ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome |
| Q37620934 | Angiotensin-converting enzyme 2 as a therapeutic target for heart failure |
| Q36109025 | Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice. |
| Q46294058 | Case-control association study of polymorphisms in the angiotensinogen and angiotensin-converting enzyme genes and coronary artery disease and systemic artery hypertension in African-Brazilians and Caucasian-Brazilians. |
| Q99553602 | Crosstalk between coronavirus disease 2019 and cardiovascular disease and its treatment |
| Q55409649 | Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease. |
| Q38083745 | Emerging markers in cardiovascular disease: where does angiotensin-converting enzyme 2 fit in? |
| Q33795353 | From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension |
| Q43777291 | High association of angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism with recurrent aphthous stomatitis |
| Q26866656 | Hypertension: what's sex got to do with it? |
| Q92838449 | Interactions between angiotensin-converting enzyme-2 polymorphisms and high salt intake increase the risk of hypertension in the Chinese Wa population |
| Q37631012 | Recent Update of Renin-angiotensin-aldosterone System in the Pathogenesis of Hypertension |
| Q92022823 | Soluble angiotensin converting enzyme 2 levels in chronic heart failure is associated with decreased exercise capacity and increased oxidative stress-mediated endothelial dysfunction |
| Q38214892 | Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases. |
| Q38705911 | The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction |
| Q38394854 | The association between angiotensin-converting enzyme 2 polymorphisms and essential hypertension risk: A meta-analysis involving 14,122 patients |
| Q27000495 | Wrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulators |
Search more.